guide question:
A. Given the following research studies, determine the type of research:
13.Isolation and characterization of coronavirus?
14.origin and transmission of coronavirus?
15.hydrolysis reaction of bamboo leaf extract against covid 19?
16.relationship of blood type and covid cases throughout the world?
17.application of anti coronavirus vaccine?
18.symptoms of coronavirus disease in human body?
19.effects of coronavirus on different ethnic groups and their cultural behavior?
20.coronavirus sustainability on various surface?
21.prevention and treatment of coronavirus infection?
22.effectiveness in remdesivir for treatment of covid 19?
A. Given the following research studies, determine the type of research:
13.Isolation and characterization of coronavirus?
14.origin and transmission of coronavirus?
15.hydrolysis reaction of bamboo leaf extract against covid 19?
16.relationship of blood type and covid cases throughout the world?
17.application of anti coronavirus vaccine?
18.symptoms of coronavirus disease in human body?
19.effects of coronavirus on different ethnic groups and their cultural behavior?
20.coronavirus sustainability on various surface?
21.prevention and treatment of coronavirus infection?
22.effectiveness in remdesivir for treatment of covid 19?
Add an Answer
More Questions From This User See All
Answers & Comments
Answer:
14. Background. In December 2019, a cluster of pneumonia cases, caused by a newly identified β-coronavirus, occurred in Wuhan, China. This coronavirus, was initially named as the 2019-novel coronavirus (2019-nCoV) on 12 January 2020 by World Health Organization (WHO).
16. Types B and AB were not at increased risk of COVID-19 infection. In terms of mortality, blood type A patients were at increased risk of death
18. Common symptoms include headache, loss of smell and taste, nasal congestion and rhinorrhea, cough, muscle pain, sore throat, fever, diarrhea, and breathing difficulties. People with the same infection may have different symptoms, and their symptoms may change over time.
22. The median recovery time was 10 days with remdesivir compared to 15 days for the placebo group. Patients given remdesivir were more likely to have improved by day 15. Remdesivir also improved mortality rates for those receiving supplemental oxygen (4% with remdesivir versus 13% with placebo at day 29 of treatment).